Literature DB >> 9083981

Interventional radiologic placement of chest wall ports: results and complications in 161 consecutive placements.

K R Simpson1, D M Hovsepian, D Picus.   

Abstract

PURPOSE: To review the technical results and long-term follow-up of the first 157 consecutive patients undergoing placement of 161 chest wall ports at the authors' institution. PATIENTS AND METHODS: All ports were placed in the interventional radiology suite with use of fluoroscopic and/or ultrasound guidance with a combination of standard interventional radiology and surgical techniques. The hospital records of all patients were reviewed, and telephone contact made when possible. Patients ranged in age from 21 to 87 years (average, 57 years). The most common indication for port placement was chemotherapy (88%).
RESULTS: Placement was technically successful in all 161 procedures. Minor procedural complications occurred in eight patients (5%). There were no major complications related to the procedure. Cumulative follow-up to date includes 35,992 port-days (average, 226 days per patient). The long-term complication rate was 8.7% or .39 per 1,000 access days, which includes nine infections and five migration-related complications.
CONCLUSION: Interventional radiologic placement of chest wall ports is safe and has a high technical success rate, in large part due to the integration of interventional radiology techniques to the procedure. The short and long-term complication rates are equal to or less than those of current surgical series.

Entities:  

Mesh:

Year:  1997        PMID: 9083981     DOI: 10.1016/s1051-0443(97)70537-2

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  7 in total

1.  A guide to antibiotics for the interventional radiologist.

Authors:  Ali Zarrinpar; Robert K Kerlan
Journal:  Semin Intervent Radiol       Date:  2005-06       Impact factor: 1.513

2.  Safety of a totally implantable central venous port system with percutaneous subclavian vein access.

Authors:  Dong-Yoon Keum; Jae-Bum Kim; Min-Cheol Chae
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-06-05

3.  Frequency of pneumothorax and haemothorax after primary open versus closed implantation strategies for insertion of a totally implantable venous access port in oncological patients: study protocol for a randomised controlled trial.

Authors:  Felix J Hüttner; Tom Bruckner; Ingo Alldinger; Roland Hennes; Alexis Ulrich; Markus W Büchler; Markus K Diener; Phillip Knebel
Journal:  Trials       Date:  2015-03-31       Impact factor: 2.279

4.  Totally implantable venous access ports and associated complications in sub-Saharan Africa: a single-centre retrospective analysis.

Authors:  Kahmil Salawu; Oreoluwa Arowojolu; Oluwasegun Afolaranmi; Mutiu Jimoh; Chukwumere Nworgu; Bode Falase
Journal:  Ecancermedicalscience       Date:  2022-05-12

Review 5.  Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature.

Authors:  J Vardy; K Engelhardt; K Cox; J Jacquet; A McDade; M Boyer; P Beale; M Stockler; R Loneragan; B Dennien; R Waugh; S J Clarke
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

6.  Protocol of an expertise based randomized trial comparing surgical Venae Sectio versus radiological puncture of Vena Subclavia for insertion of Totally Implantable Access Port in oncological patients.

Authors:  Philip Knebel; Lars Fischer; Eva Cremonese; Ruben Lopez-Benitez; Ulrike Stampfl; Boris Radeleff; Hans-Ulrich Kauczor; Markus W Büchler; Christoph M Seiler
Journal:  Trials       Date:  2008-10-24       Impact factor: 2.279

7.  Image-guided chemoport insertion by interventional radiologists: A single-center experience on periprocedural complications.

Authors:  Yazmin Yaacob; Dang V Nguyen; Zahiah Mohamed; A Razali A Ralib; Rozman Zakaria; Sobri Muda
Journal:  Indian J Radiol Imaging       Date:  2013-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.